NYSE$CLB
Core Laboratories Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
CLB Q2 2024 — TRY 96.3M revenue
In the opinion of management, all adjustments considered necessary for a fair statement of the results for the interim periods presented have been included in these financial statements. Core Laboratories Inc reported Q2 2024 results. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: TRY 96.3M.
- Operating income: TRY 16K.
- Filed on Form 10-Q (accession 0000950170-24-086610).
Headline financials
Revenue & EPS history
Core Labs · Revenue · Quarterly
$131M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 9 quarterly earnings reports · overlaid with Q2 2024
+4.1%
Avg return
Earnings day
+2.8%
Avg return
5 days after
-3.7%
Avg return
30 days after
67%
6 / 9 earnings
Positive
+28.8%
Q3 2025
Best reaction
-15.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.3% | -17.7% | -21.2% | |
| Q4 2025 | -4.2% | -4.9% | -18.9% | |
| Q3 2025 | +28.8% | +29.0% | +15.3% | |
| Q1 2025 | +2.2% | -2.1% | -6.5% | |
| Q3 2024 | +10.9% | +14.2% | +24.6% | |
| Q2 2024 | +10.6% | +11.2% | -16.6% | |
| Q1 2024 | +3.3% | -4.4% | +8.4% | |
| Q3 2023 | +1.1% | -10.8% | -14.0% | |
| Q2 2023 | -0.8% | +10.6% | -4.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro